Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Acute Coronary Syndrome
Interventions
DRUG

generic clopidogrel (Plavitor® )

DRUG

original clopidogrel (Plavix® )

Trial Locations (1)

443-720

Ajou University Hospital, Suwon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dong-A Pharmaceutical

INDUSTRY

lead

Ajou University School of Medicine

OTHER

NCT02060786 - Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®) | Biotech Hunter | Biotech Hunter